NCT06933836Recruiting

DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma

Barnet Dulaney Perkins Eye Centers

Start Date

3/31/2025

Completion Date

12/31/2027

Summary

DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.

Detailed Description

DSLT enables newly diagnosed patients to remain well controlled and off medications

Eligibility Criteria

Age Range: 30 years to No maximum

Inclusion Criteria: * Primary open angle glaucoma * Patients age 30 or greater with an IOP of 18-26 mmHg * Mild to moderate POAG patients (mild or moderate according to the AAO PPP Guidelines) * DSLT procedure Exclusion Criteria: * History of prior glaucoma treatment - this includes past medication use (in either eye), previous lasers or incisional surgery * Angle closure patients * Ocular Hypertension * Baseline VF MD of worse than -12dB * Uncontrolled systemic microvascular disease (eg. HTN, DM) * Subjects with peri-limbal findings (e.g. melanosis, tumors, extensive pterygium, significant senile arcus and pterygium)

Interventions

DEVICE

DSLT enables newly diagnosed patients to remain well controlled and off medications

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Open Angle Glaucoma (OAG)

Locations

Barnet Dulaney Perkins Eye Centers

Mesa, Arizona 85206

United States